Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme (Q48058166)
Jump to navigation
Jump to search
scientific article published on 15 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme |
scientific article published on 15 October 2014 |
Statements
1 reference
Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme (English)
1 reference
M Moehler
1 reference
A Maderer
1 reference
C Schimanski
1 reference
S Kanzler
1 reference
U Denzer
1 reference
F T Kolligs
1 reference
M P Ebert
1 reference
A Distelrath
1 reference
M Geissler
1 reference
J Trojan
1 reference
M Schütz
1 reference
L Berie
1 reference
C Sauvigny
1 reference
F Lammert
1 reference
A Lohse
1 reference
M M Dollinger
1 reference
U Lindig
1 reference
E M Duerr
1 reference
N Lubomierski
1 reference
S Zimmermann
1 reference
D Wachtlin
1 reference
A-K Kaiser
1 reference
S Schadmand-Fischer
1 reference
P R Galle
1 reference
M Woerns
1 reference
Working Group of Internal Oncology
1 reference
15 October 2014
1 reference
50
1 reference
18
1 reference
3125-3135
1 reference
Identifiers
1 reference